Kura Oncology KURA Cash Flow Statement (2010-2026)

NASDAQ KURA
$10.71 -0.10 (-0.93%)
At close: Sep 30, 2026 · 4:00 PM EDT
Reported Financials

Kura Oncology Quarterly Cash Flow Statement

Periods 64 quarters
Latest Jun 2026

Kura Oncology reported cash from operations of -$62.55M and free cash flow of -$63.20M for the quarter ended Jun 2026, down 117.4% year over year. This cash flow statement covers 64 quarters of results from Sep 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-49.52M-50.84M-54.40M-17.20M-57.43M-66.12M-74.12M-81.00M-73.33M-68.33M
Depreciation and Depletion
0.16M0.21M0.18M0.18M0.19M0.25M0.21M0.21M0.22M0.21M0.23M0.20M0.21M0.20M0.24M0.22M0.16M0.40M0.35M0.37M
Share-based Compensation
6.11M6.40M6.65M6.51M6.36M6.80M6.84M6.99M7.09M7.17M8.51M8.43M8.32M8.63M7.84M6.95M10.96M11.35M8.42M8.21M
Cash from Operations
-24.59M-23.37M-32.18M-30.34M-21.01M-26.53M-35.87M-25.62M-29.03M-34.31M-48.84M-42.53M-43.44M269.13M-71.93M-28.78M-80.63M117.27M-85.85M-62.55M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Depreciation & Amortization
0.16M0.21M0.18M0.18M0.19M0.25M0.21M0.21M0.22M0.21M0.23M0.20M0.21M0.20M0.24M0.22M0.16M0.40M0.35M0.37M
Change in Working Capital
Change in Receivables
46.69M-44.17M31.36M-27.13M0.54M0.10M
Change in Inventory
0.43M1.64M
Change in Account Payables
3.14M-2.91M2.03M-4.65M
Change in Accured Expenses
0.14M0.03M-5.25M-0.34M6.35M-1.56M-5.36M4.11M3.93M8.57M-3.13M-0.05M5.68M14.33M-8.61M10.41M13.02M-2.16M-16.22M9.66M
Other Working Capital Changes
-0.68M-1.13M2.63M2.57M-0.91M-1.35M2.11M-1.88M-0.80M2.53M2.19M-1.88M-0.94M278.81M34.59M-10.83M15.66M156.29M-9.44M-10.36M
Investing Activities
Capital Expenditures
0.72M0.10M0.05M0.18M0.38M0.01M0.04M0.10M0.02M0.02M0.08M0.02M0.37M0.29M1.46M2.57M2.32M0.13M0.66M
Cash from Investing Activities
22.55M74.06M-24.96M33.10M71.81M-47.32M11.13M-46.33M8.56M42.20M-95.34M43.17M45.53M-94.95M-101.41M58.94M93.97M-64.60M-24.23M92.21M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt Issuances
Long-Term Debt Repayments
Change in Capital Stock
Net Equity Issued and Repurchased
2.26M0.79M0.30M2.67M0.88M0.57M0.08M0.69M2.56M3.04M2.20M0.81M0.14M0.52M1.14M0.07M1.50M
Misc.
Cash from Financing Activities
2.26M0.79M0.30M2.67M0.88M34.71M0.08M0.69M148.37M3.04M2.20M0.81M0.14M0.52M1.14M0.07M1.50M
Change in Cash
0.21M51.49M-56.84M5.42M51.68M-39.13M-24.74M22.07M-20.38M8.58M4.19M3.68M4.30M174.98M-173.19M30.68M13.34M53.81M-110.02M31.16M
Free Cash Flow
-25.32M-23.47M-32.23M-30.52M-21.39M-26.54M-35.91M-25.71M-29.05M-34.32M-48.93M-42.55M-43.44M268.76M-72.22M-30.23M-83.19M114.95M-85.98M-63.20M
Net Cash Flow
0.21M51.49M-56.84M5.42M51.68M-39.13M-24.74M-71.94M-20.38M8.58M4.19M3.68M4.30M174.98M-173.19M30.68M13.34M53.81M-110.02M31.16M

Kura Oncology Cash Flow Statement API

Pull Kura Oncology's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=KURA&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY